1.51
price down icon3.09%   -0.05
after-market Handel nachbörslich: 1.51
loading
Schlusskurs vom Vortag:
$1.56
Offen:
$1.56
24-Stunden-Volumen:
1.98M
Relative Volume:
0.84
Marktkapitalisierung:
$1.20B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-7.9474
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
-3.09%
1M Leistung:
+7.22%
6M Leistung:
+11.16%
1J Leistung:
+2.84%
1-Tages-Spanne:
Value
$1.50
$1.57
1-Wochen-Bereich:
Value
$1.50
$1.60
52-Wochen-Spanne:
Value
$1.11
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
Firmenname
Opko Health Inc
Name
Telefon
305-575-4181
Name
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Name
Mitarbeiter
2,997
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
OPK's Discussions on Twitter

Vergleichen Sie OPK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
OPK
Opko Health Inc
1.51 1.24B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.70 201.90B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
202.45 146.42B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
616.15 50.30B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
136.63 39.72B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
198.13 34.51B 15.70B 1.24B 2.01B 6.9036

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-25 Eingeleitet JP Morgan Neutral
2023-06-29 Hochstufung Barrington Research Mkt Perform → Outperform
2022-12-15 Eingeleitet H.C. Wainwright Buy
2022-01-24 Herabstufung Barrington Research Outperform → Mkt Perform
2021-06-21 Eingeleitet Ladenburg Thalmann Buy
2019-11-25 Eingeleitet Piper Jaffray Overweight
2018-03-02 Herabstufung JP Morgan Neutral → Underweight
2017-09-14 Herabstufung JP Morgan Overweight → Neutral
2016-06-21 Bestätigt Standpoint Research Buy
2016-06-03 Eingeleitet Standpoint Research Buy
2016-03-31 Bestätigt Barrington Research Outperform
2015-10-16 Eingeleitet JP Morgan Overweight
2015-09-11 Herabstufung Jefferies Buy → Hold
2015-03-03 Herabstufung Oppenheimer Outperform → Perform
2014-05-12 Bestätigt Oppenheimer Outperform
2014-03-14 Eingeleitet Oppenheimer Outperform
2013-11-13 Bestätigt Ladenburg Thalmann Buy
2013-05-30 Bestätigt Ladenburg Thalmann Buy
2012-10-22 Eingeleitet Barrington Research Outperform
2011-12-01 Bestätigt Ladenburg Thalmann Buy
2011-07-14 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Opko Health Inc Aktie (OPK) Neueste Nachrichten

pulisher
08:06 AM

OPKO Health (NASDAQ:OPK) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

08:06 AM
pulisher
05:27 AM

Clinical Laboratory Tests Market See Incredible Growth 2025-2032 | ARUP Laboratories, OPKO Health, Inc., UNILABS - industrytoday.co.uk

05:27 AM
pulisher
Oct 09, 2025

Smart tools for monitoring OPKO Health Inc.’s price actionJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Real time pattern detection on OPKO Health Inc. stock2025 Technical Overview & Low Drawdown Trading Strategies - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

NextPlat Issues CEO Shareholder Update Letter - Benzinga

Oct 08, 2025
pulisher
Oct 07, 2025

OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo

Oct 07, 2025
pulisher
Oct 06, 2025

OPKO acquiring company from Barcelona - Law.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can machine learning forecast OPKO Health Inc. recoveryPortfolio Return Summary & Safe Entry Zone Identification - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How OPKO Health Inc. stock performs in weak economyJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why OPKO Health Inc. stock attracts global investorsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Technical signs of recovery in OPKO Health Inc.July 2025 Highlights & Fast Moving Market Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How OPKO Health Inc. (XCY) stock reacts to stronger dollarJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to manage a losing position in OPKO Health Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Ranking OPKO Health Inc. among high performing stocks via toolsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What institutional flow reveals about OPKO Health Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

OPKO Health (OPK): Valuation Insights as Clinical Pipeline Progress and Asset Sales Draw Investor Focus - Sahm

Oct 05, 2025
pulisher
Oct 04, 2025

Washington Growth Strategies LLC Has $1.79 Million Position in OPKO Health, Inc. $OPK - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and CEO Boosts Stake Has the Bull Case Changed? - Sahm

Oct 03, 2025
pulisher
Oct 03, 2025

Why OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and Notable Insider Buying - Sahm

Oct 03, 2025
pulisher
Oct 03, 2025

Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance

Oct 01, 2025
pulisher
Sep 30, 2025

What analysts say about OPKO Health Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Labcorp to buy certain assets of OPKO unit BioReference Health - MSN

Sep 30, 2025
pulisher
Sep 29, 2025

12 Healthcare Stocks with Insider Buying in 2025 - Insider Monkey

Sep 29, 2025
pulisher
Sep 27, 2025

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - MSN

Sep 27, 2025
pulisher
Sep 25, 2025

Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis Farma - Barchart.com

Sep 25, 2025
pulisher
Sep 23, 2025

44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

Opko Health, Inc. (OPK) Stock Analysis: Unlocking a Potential 151% Upside with Strategic Healthcare Innovations - DirectorsTalk Interviews

Sep 23, 2025
pulisher
Sep 23, 2025

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Lowers Position in OPKO Health, Inc. $OPK - MarketBeat

Sep 23, 2025

Finanzdaten der Opko Health Inc-Aktie (OPK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Opko Health Inc-Aktie (OPK) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 10 '25
Buy
1.36
125,000
169,712
214,001,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 08 '25
Buy
1.48
125,000
184,650
213,876,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 01 '25
Buy
1.65
100,000
164,850
213,751,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 28 '25
Buy
1.70
150,000
254,385
213,651,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 17 '25
Buy
1.74
200,000
347,820
213,501,448
FROST PHILLIP MD ET AL
CEO & Chairman
Feb 28 '25
Buy
1.71
67,434
115,312
213,301,448
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 28 '25
Buy
1.47
47,537
70,060
213,234,014
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 17 '25
Buy
1.47
150,000
220,425
213,186,477
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 15 '25
Buy
1.48
500,000
740,850
213,036,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 13 '24
Buy
1.59
125,000
199,375
212,536,477
diagnostics_research WAT
$331.01
price up icon 0.31%
diagnostics_research DGX
$184.17
price up icon 1.55%
diagnostics_research LH
$277.94
price up icon 0.09%
$169.27
price down icon 2.32%
diagnostics_research MTD
$1,275.72
price down icon 2.56%
diagnostics_research IQV
$198.13
price down icon 2.30%
Kapitalisierung:     |  Volumen (24h):